Navigation Links
European Nurse Society Calls to Action on Breakthrough Cancer Pain
Date:10/7/2010

European Nurse Society Calls to Action on Breakthrough Cancer Pain -- BRUSSELS, October 7, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services, Clinical Trials & Medical Discoveries Click to view news release full screen  

European Nurse Society Calls to Action on Breakthrough Cancer Pain

 

BRUSSELS, October 7, 2010 /PRNewswire/ -- The European Oncology Nursing Society (EONS) launches first European nurse initiative to examine current practices in Breakthrough Cancer Pain and look at ways of improving patient outcomes in palliative care

The Breakthrough Cancer Pain Initiative is a nurse-driven initiative launched with the purpose of improving breakthrough pain management for cancer patients.

"Patient surveys have shown that breakthrough cancer pain is under-recognised, sub-optimally treated and therefore subject of intense patient discomfort. We believe that oncology nurses have an important role in identifying and managing Breakthrough Cancer Pain and with this initiative we hope to make oncology nurses across Europe realise that and bring their skills into play," says Yvonne Wengstrom, Associated Prof. of Cancer Nursing at Karolinska Institutet, Stockholm and former president of EONS.

To drive the Breakthrough Cancer Pain Initiative, a European working group of oncology nurses with a special interest in palliative care has been formed. As a first step the working group has prepared a survey that will look into the general understanding of Breakthrough Cancer Pain amongst oncology nurses, confidence in treating these episodes, examples of best practice as well as gaps in current practice.

A multidisciplinary advisory group of recognised international experts in the field of Breakthrough Cancer Pain provides further expertise to the development of the survey and provides insights on Breakthrough Cancer Pain based on their knowledge within palliative care in general and Breakthrough Cancer Pain in particular.

"The survey will provide valuable information about any knowledge gaps and whether there is a need for further education. Based on this information the second stage of this project will involve the Breakthrough Cancer Pain Working Group considering what materials could be developed to best help the nursing community to improve the outcome of Breakthrough Cancer Pain management," says Jenske Geerling, oncology nurse at the University Medical Center at Groningen, The Netherlands and member of the Breakthrough Cancer Pain Working Group.

The survey, which is the first of its kind, will run over the next couples of weeks in The Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Norway, Slovenia, Sweden, The Netherlands, and The UK. The countries have been carefully selected in order to provide a broad platform for examining palliative care nursing practice across Europe.

"Assessment and management of breakthrough cancer pain depends on the education and knowledge of the healthcare team, especially nurses, who work closely with patients and their families. This survey should pinpoint the needs and will lead to improvements in the management of breakthrough cancer pain," says Associate Professor Sultan Kav, President of EONS.

The need for an initiative like this is recognised by the international palliative care committee formed with the purpose of improving palliative care for cancer patients:

"An initiative like this is very important. Supportive and palliative care is far from fully integrated into medical oncology practice. Variations in cancer pain intensity are highly prevalent, yet the phenomenon of Breakthrough Cancer Pain is not well understood. Hopefully this initiative will lead to a better understanding of these episodes and how they are best managed to the benefit of cancer patients across Europe," says Dr. Nathan Cherny, Chair of The Palliative Care Working Group (PCWG) under ESMO.

To learn more about the Breakthrough Cancer Pain Initiative, please visit: http://www.cancernurse.eu/research/breakthroughcancerpain.html. The initiative is supported with an educational grant by Nycomed International GmbH.

About EONS

The European Oncology Nursing Society is a pan-European organisation founded in 1984 and registered as an independent charity. Its activities aim to promote a healthier future for people affected by cancer, ensuring that they will benefit from the care of well educated, perceptive and proficient cancer nurses. EONS represents the voice of more than 22.000 cancer nurses. For more information, please visit: http://www.cancernurse.eu

Breakthrough Cancer Pain

A transient (episodic) exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain(1).

References

1) Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. European Journal of Pain 2009; 13(4): 331-8.

Contact details Yvonne Wengstrom Assoc. Prof. Cancer Nursing Karolinska Institute, Sweden Former president of EONS Phone: +46-8-524-83683 Jenske Geerling UMCG, The Netherlands Phone: +31-50-3616161 Email: j.i.geerling@int.umcg.nl
'/>"/>

SOURCE European Oncology Nursing Society (EONS)
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. YM Biosciences To Present Poster On CYT387 At The European School Of Haematology International Conference
2. ASEBIO Requests the Alignment of Spain With the European Unions Future Strategy of Bioeconomy
3. Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting
4. Caliper Life Sciences CEO to Present Keynote Presentation at MipTec European Conference
5. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
6. DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinical™ for Pan-European Systolic Hypertension Study
7. European Union Approves Maize with Herculex® I/Herculex® RW and Herculex® RW/ Herculex® I/Roundup Ready® Corn 2 Trait Stacks for Import, Food, Feed & Processing
8. European cooperation ensures global leadership in microelectronics
9. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
10. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
11. ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Research and Markets has announced the addition of the ... ... provides separate comprehensive analytics for the US, Japan ... estimates and forecasts are provided for the period 2015 through 2022. ... data and analytics are derived from primary and secondary research. This ...
(Date:2/17/2017)... 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today ... peptide drug candidates, PTG-100 and PTG-200, at the ... and Colitis Organization (ECCO).  The ECCO congress is ... from February 15 – 18, 2017. ... Protagonist drug candidates PTG-100 and PTG-200. PTG-100, a ...
(Date:2/16/2017)... WEST PALM BEACH, Fla. , Feb. 16, ... molecular diagnostics company revolutionizing the development of liquid ... that it has entered into an exclusive license ... who will distribute MDNA,s proprietary liquid biopsy test ... in South Korea . This ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology:
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... fastest growing genetic information companies, today announced that it ... results and provide 2017 guidance on Monday, February 13, ... call that day at 4:45 p.m. Eastern / 1:45 ... management team will briefly review financial results, guidance, and ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
(Date:1/18/2017)... -- In vitro diagnostic (IVD) companies were very active in ... Kalorama Information expects that trend to continue – though ... uncertainty in reimbursement and healthcare reform in ... acquisitions landscape. Instead of looking to buy technology, the ... of their home country and also to increase their ...
Breaking Biology News(10 mins):